Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD)
India · Delayed Price · Currency is INR 447.25
-3.95 (-0.88%)
Jan 27, 2026, 3:29 PM IST
NSE:SRHHYPOLTD Revenue
Sree Rayalaseema Hi-Strength Hypo had revenue of 1.82B INR in the quarter ending September 30, 2025, with 7.14% growth. This brings the company's revenue in the last twelve months to 6.62B, down -7.93% year-over-year. In the fiscal year ending March 31, 2025, Sree Rayalaseema Hi-Strength Hypo had annual revenue of 6.38B, down -26.35%.
Revenue (ttm)
6.62B
Revenue Growth
-7.93%
P/S Ratio
1.17
Revenue / Employee
12.82M
Employees
516
Market Cap
7.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.38B | -2.28B | -26.35% |
| Mar 31, 2024 | 8.66B | -7.84B | -47.52% |
| Mar 31, 2023 | 16.50B | 3.83B | 30.21% |
| Mar 31, 2022 | 12.67B | 3.56B | 39.13% |
| Mar 31, 2021 | 9.11B | 2.22B | 32.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chemplast Sanmar | 43.42B |
| Gujarat Alkalies and Chemicals | 42.93B |
| GHCL Limited | 30.77B |
| Epigral | 24.67B |
| The Andhra Sugars | 22.09B |
| DCW Limited | 20.27B |
| Godavari Biorefineries | 19.95B |
| Kanoria Chemicals & Industries | 15.88B |
Sree Rayalaseema Hi-Strength Hypo News
- 1 year ago - Sree Rayalaseema Hi-Strength Hypo shares surge 17% on heavy volumes - Business Upturn
- 1 year ago - Sree Rayalaseema Hi-Strength Hypo shares surge over 10% on high volumes - Business Upturn